Clinical And Radiation Oncology Society Of Zambia

Clinical And Radiation Oncology Society Of Zambia, an international not-for-profit organization based in Lusaka, Zambia, operates exclusively as a sub-recipient on federal biomedical research grants rather than as a prime contractor or prime grantee. The organization has received three sub-awards across two distinct federal agencies totaling $105 thousand in combined obligated dollars since December 2023, with all work performed under the administrative oversight of U.S.-based prime grantees.

The organization's grant footprint centers on cancer research and treatment. The National Institutes of Health National Cancer Institute (part of the Department of Health and Human Services) funds two active sub-awards: a May 2026 sub-award from the American Society For Clinical Pathology supporting subject recruitment and data collection for a research project titled "Enhancing Precision Oncology for Breast Cancer Patients through Deep-Learning-Aided Histopathology Analysis," and a February 2026 R01 sub-award from The University of Texas M.D. Anderson Cancer Center in which Clinical And Radiation Oncology Society Of Zambia serves as a multi-principal investigator site responsible for institutional review board approval, regulatory oversight, patient consent and recruitment, data collection, specimen collection, and long-term follow-up on a prospective breast cancer cohort study. A third sub-award from December 2023, funded through the Defense Health Agency via Implenomics LLC, supported strategy testing to increase cancer treatment completion among adolescents and young adults. Clinical And Radiation Oncology Society Of Zambia's role across these grants centers on patient recruitment, data collection, specimen handling, regulatory compliance, and site management for cancer research protocols conducted in Zambia with U.S. federal research sponsorship and U.S.-based principal investigator institutions.